Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010443 |
---|---|
Receipt number | R000012208 |
Scientific Title | Randomized phase II trial of Carboplatin plus weekly nab-Paclitaxel versus Cisplatin plus Gemcitabine in patients with chemo-naive stage IIIB/IV or postoperative recurrent squamous cell lung cancer |
Date of disclosure of the study information | 2013/04/22 |
Last modified on | 2019/04/15 14:17:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/08 20:46:24 | ||
2 | Update | 2013/04/11 15:52:02 | Research ethics review |
|
3 | Update | 2013/05/18 22:32:28 | Research ethics review |
|
4 | Update | 2013/05/18 22:32:45 | Recruitment status |
|
5 | Update | 2013/09/09 12:46:59 | Address TEL Address Address |
|
6 | Update | 2013/09/09 12:49:40 | ||
7 | Update | 2016/04/09 13:47:35 | Name of primary person or sponsor Organization |
|
8 | Update | 2018/10/15 19:52:15 | Email |
|
9 | Update | 2018/10/15 19:53:02 | Recruitment status |
|
10 | Update | 2019/04/15 12:16:53 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date Date trial data considered complete Date analysis concluded |
|
11 | Update | 2019/04/15 12:19:28 | Number of participants that the trial has enrolled |
|
12 | Update | 2019/04/15 12:33:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Division name Zip code Address Last name of contact person Last name of contact person Organization Division name Zip code Organization Division name Name of primary person or sponsor Address1 Email1 Organization Organization Address Address Tel |
|
13 | Update | 2019/04/15 14:17:42 | Organization |